Dr. Benjamin Brian Bert, MD

Dr. Bert practices at UCLA Medical Center in Los Angeles, California.

Dr. Bert's NPI, 1518129964, was assigned on June 26, 2008. Dr. Bert graduated from SUNY Upstate Medical University in 2008. Dr. Bert holds California license A120092.

Dr. Bert's primary practice is UCLA Medical Center, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 206-4083.

Dr. Bert's primary practice is UCLA Medical Center in Los Angeles, California. Dmand AI also links Dr. Bert to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bert practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Bert's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Bert is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Bert's licenses on file in 2 states: California and New York.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Bert treats.

CMS data shows 2,427 Medicare services from Dr. Bert across 15 procedure codes in 2024, for 1,068 Medicare patients. Medicare paid $257,950 for them.

CMS counts 1,068 Medicare patients who saw Dr. Bert in 2024. The largest group is 75 to 84, with 487 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bert's median patient age at 72, with 60% women.

In 2024, Dr. Bert wrote 2,280 Medicare Part D claims for 497 patients. 50% of them were for generic drugs. CMS names the drug for 2,169 of them, across 28 drugs with 11 or more claims each, at $379,150 in total drug cost. In 2023, CMS named 2,080 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Bert for performance year 2024, reported as part of a group. Dr. Bert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bert as offering telehealth. CMS counts 257 procedures of cataract surgery by Dr. Bert, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Bert in 2025. Dr. Bert's most frequent co-author is Tatyana Milman, MD.

Dmand AI links Dr. Bert to 1 clinical trial. Conditions studied include Glaucoma and Ocular Hypertension.

CMS Open Payments shows 136 general payments to Dr. Bert from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Sun Pharmaceutical Industries Inc. paid the most, $491.

Dmand AI lists 3 awards for Dr. Bert, most recently Resident Teaching Award in 2014.

Dr. Bert graduated from SUNY Upstate Medical University in 2008. Dr. Bert is a member of AAO, ACS and ASCRS.

Dr. Bert is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.